Advancements in Psychiatric Treatment Targets for Posttraumatic Stress Disorder (original) (raw)

Advancements in the understanding of the neurobiological mechanisms underlying Posttraumatic Stress Disorder (PTSD) are leading to the exploration of novel pharmacological treatments. Traditional treatments such as SSRIs and SNRIs, while effective, have left a gap for new interventions targeting other neurochemical, genetic, and immunological pathways. The potential for increased efficacy lies in addressing persistent low-grade inflammation and dysregulations in neurotransmitter systems, paving the way for tailored approaches to improve patient outcomes.